MNPR logo
Monopar Therapeutics Inc.(MNPR)
Last print unknown agoAbout this dataData status
$71.47▲2.20 (3.18%)Stale · unknown old

MNPR Operating Cash Flow (Statement)

-$3.26BTTM · USD

Period ending:

MNPR FY Cash from OperationsUSD
MNPR FY Cash from Operations2015-12-31: -$636.33K2016-12-31: -$1.19M2017-12-31: -$2.63M2018-12-31: -$2.89M2019-12-31: -$3.02M2020-12-31: -$4.66M2021-12-31: -$7.32M2022-12-31: -$7.23M2023-12-31: -$7.86M2024-12-31: -$6.40M2025-12-31: -$12.20M$0.00-$12.20M
2015-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MNPR operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 11 observations from Dec 31, 2015 to Dec 31, 2025.

Monopar Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-12,201,291
-6,404,139
-7,858,293
-7,228,559
-7,317,401
-4,662,274
-3,017,680
-2,886,757
-2,627,468
-1,194,632
-636,328

Compare operating cash flow (statement)

All MNPR financial metrics · MNPR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.